SEARCH

SEARCH BY CITATION

References

  • Abels, R.I. (1992) Recombinant human erythropoietin in the treatment of the anaemia of cancer. Acta Haematologica, 87, 411.
  • Abels, R. (1993) Erythropoietin for anaemia in cancer patients. European Journal of Cancer, 29A, S2S8.
  • Barlogie, B. & Beck, T. (1993) Recombinant human erythropoietin and the anemia of multiple myeloma. Stem Cells, 11, 8894.
  • Beguin, Y. (1995) Erythropoiesis and erythropoietin in multiple myeloma. Leukemia and Lymphoma, 18, 413421.
  • Cella, D. (1998) Factors influencing quality of life in cancer patients: anemia and fatigue. Seminars in Oncology, 25, 4346.
  • Dammacco, F., Silvestris, F., Castoldi, G.L., Grassi, B., Bernasconi, C., Nadali, G., Perona, G., DeLaurenzi, A., Torelli, U., Ascari, E., Rossi Ferrini, P.L., Caligaris-Cappio, F., Pileri, A. & Resegotti, L. (1998) The effectiveness and tolerability of epoetin alfa in patients with multiple myeloma refractory to chemotherapy. International Journal of Clinical and Laboratory Research, 28, 127134.DOI: 10.1007/s005990050032
  • Demetri, G.D., Kris, M., Wade, J., Degos, L. & Cella, D. for the Procrit Study Group (1998) Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Journal of Clinical Oncology, 16, 34123425.
  • Dunphy, F.R., Dunleavy, T.L., Harrison, B.R., Boyd, J.H., Varvares, M.H., Dunphy, C.H., Rodriguez, J.J., McDonough, E.M., Minster, J.R. & McGrady, M.D. (1997) Erythropoietin reduces anemia and transfusions after chemotherapy with paclitaxel and carboplatin. Cancer, 79, 16231628.DOI: 10.1002/(sici)1097-0142(19970415)79:8<1623::aid-cncr28>3.3.co;2-p
  • Durie, B.G. & Salmon, S.E. (1975) A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer, 36, 842854.
  • Garton, J.P., Gertz, M.A., Witzig, T.E., Greipp, P.R., Lust, J.A., Schroeder, G. & Kyle, R.A. (1995) Epoetin alfa for the treatment of the anemia of multiple myeloma. A prospective, randomized, placebo-controlled, double-blind trial. Archives of Internal Medicine, 155, 20692074.DOI: 10.1001/archinte.155.19.2069
  • Glaspy, J., Bukowski, R., Steinberg, D., Taylor, C., Tchekmedyian, S. & Vadhan-Raj, S. for the Procrit Study Group (1997) Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Journal of Clinical Oncology, 15, 12181234.
  • Goodnough, L.T., Brecher, M.E., Kanter, M.H. & AuBuchon, J.P. (1999) Medical progress: transfusion medicine (first of two parts) – blood transfusion. New England Journal of Medicine, 340, 438447.DOI: 10.1056/NEJM199902113400606
  • Hjorth, M., Holmberg, E., Rödjer, S. & Westin, J. for the Myeloma Group of Western Sweden (1992) Impact of active and passive exclusions on the results of a clinical trial of multiple myeloma. British Journal of Haematology, 80, 5561.
  • Hunt, S.M. & McKenna, S.P. (1989) European Guide to the Nottingham Health Profile, Rev. edn. The European Group for QOL and Health Measurements, London.
  • Kyle, R.A. (1975) Multiple myeloma. Review of 869 cases. Mayo Clinic Proceedings, 50, 2940.
  • Leitgeb, C., Pecherstorfer, M., Fritz, E. & Ludwig, H. (1994) Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin. Cancer, 73, 25352542.
  • Ludwig, H. & Fritz, E. (1998) Anemia in cancer patients. Seminars in Oncology, 25, 26.
  • Ludwig, H., Fritz, E., Kotzmann, H., Hocker, P., Gisslinger, H. & Barnas, U. (1990) Erythropoietin treatment of anemia associated with multiple myeloma. New England Journal of Medicine, 322, 16931699.
  • Ludwig, H., Fritz, E., Leitgeb, C., Krainer, M., Kührer, I., Sagaster, P. & Umek, H. (1993) Erythropoietin treatment for chronic anemia of selected hematological malignancies and solid tumors. Annals of Oncology, 4, 161167.
  • Ludwig, H., Sundal, E., Pecherstorfer, M., Leitgeb, C., Bauernhofer, T., Beinhauer, A., Samonigg, H., Kappeler, A.W. & Fritz, E. (1995) Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy. Cancer, 76, 23192329.
  • Mittelman, M., Zeidman, A., Fradin, Z., Magazanik, A., Lewinski, U.H. & Cohen, A. (1997) Recombinant human erythropoietin in the treatment of multiple myeloma-associated anemia. Acta Haematologica, 98, 204210.
  • Musto, P., Falcone, A., D'Arena, G., Scalzulli, P.R., Matera, R., Minervini, M.M., Lombardi, G.F., Modoni, S., Longo, A. & Carotenuto, M. (1997) Clinical results of recombinant erythropoietin in transfusion-dependent patients with refractory multiple myeloma: role of cytokines and monitoring of erythropoiesis. European Journal of Haematology, 58, 314319.
  • Riccardi, A., Gobbi, P.G., Ucci, G., Bertolini, D., Luoni, R., Rutigliano, L. & Ascari, E. (1991) Changing clinical presentation of multiple myeloma. European Journal of Cancer, 27, 14011405.
  • San Miguel, J.F., Bladé Creixenti, J. & García-Sanz, R. (1999) Treatment of multiple myeloma. Haematologica, 84, 3658.
  • Schwartz, A.L. (1998) The Schwartz Cancer Fatigue Scale: testing reliability and validity. Oncology Nursing Forum, 25, 711717.
  • Silvestris, F., Romito, A., Fanelli, P., Vacca, A. & Dammacco, F. (1995) Long-term therapy with recombinant human erythropoietin (rHu-EPO) in progressing multiple myeloma. Annals of Hematology, 70, 313318.DOI: 10.1007/s002770050074
  • Stronks, D.L., Passchier, J. & Heule, F. (1995) Psychosocial effects of skin treatment with imedeen. Psychological Reports, 77, 811816.
  • Turesson, I., Zettervall, O., Cuzick, J., Waldenstrom, J.G. & Velez, R. (1984) Comparison of trends in the incidence of multiple myeloma in Malmo, Sweden, and other countries. 1950–79. New England Journal of Medicine, 310, 421424.
  • Winningham, M.L., Nail, L.M., Burke, M.B., Brophy, L., Cimprich, B., Jones, L.S., Pickard-Holley, S., Rhodes, V., St. Pierre, B., Beck, S., Glass, E.C., Mock, V.L., Mooney, K.H. & Piper, B. (1994) Fatigue and the cancer experience: the state of the knowledge. Oncology Nursing Forum, 21, 2336.